FDA Chief Counsel Bradshaw's "Practical" Approach Applauded By Barr
This article was originally published in The Pink Sheet Daily
Executive Summary
Barr CEO Bruce Downey is praising FDA Chief Counsel Sheldon Bradshaw's attitude towards issues affecting the generic drug industry